Orchard Therapeutics plc
ORTXDelisted Jan 24, 2024- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001748907
Orchard Therapeutics plc was delisted on Jan 24, 2024; its insiders filed their last Form 4 on Jan 24, 2024; 47 institutions reported holding it in 13F filings for Q4 2023, worth $122.0M in total; no superinvestor held it.
13F holders, Q1 2024
Institutional positions in Orchard Therapeutics plc as of Mar 31, 2024. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
ORTX is no longer listed, and 13F filings after Q4 2023 list far fewer holders. See Q4 2023
- Institutional holders
- 0
- −47 vs. Q4 2023
- Shares held
- 0
- −8.85M (−100.0%) vs. Q4 2023
- Total value
- $0
- −$122.0M (−100.0%) vs. Q4 2023
- New holders
- 0
- 0 more added
- Sold out
- 47
- 0 more reduced
Compare with Q4 2023: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting ORTX on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 0 | $0 |
| Q1 2026 | 0 | $0 |
| Q4 2025 | 0 | $0 |
| Q3 2025 | 0 | $0 |
| Q2 2025 | 0 | $0 |
| Q1 2025 | 0 | $0 |
| Q4 2024 | 0 | $0 |
| Q3 2024 | 0 | $0 |
| Q2 2024 | 0 | $0 |
| Q1 2024 | 0 | $0 |
| Q4 2023 | 47 | $122.0M |
| Q3 2023 | 32 | $46.9M |
| Q2 2023 | 33 | $26.2M |
| Q1 2023 | 35 | $31.2M |
| Q4 2022 | 47 | $16.3M |
| Q3 2022 | 47 | $24.7M |
| Q2 2022 | 50 | $30.2M |
| Q1 2022 | 61 | $38.9M |
| Q4 2021 | 72 | $84.6M |
| Q3 2021 | 79 | $167.4M |
| Q2 2021 | 85 | $350.8M |
| Q1 2021 | 83 | $546.3M |
Institutions, Q1 2024
Shares, value and share of portfolio for each institution holding Orchard Therapeutics plc; share changes are against Q4 2023.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Deep Track Capital, LP | 0 | $0 | 0.00% | −2,041,670−100.0% | Sold out |
| Beryl Capital Management LLC | 0 | $0 | 0.00% | −1,561,499−100.0% | Sold out |
| Federated Hermes, Inc. | 0 | $0 | 0.00% | −869,327−100.0% | Sold out |
| LMR Partners LLP | 0 | $0 | 0.00% | −332,223−100.0% | Sold out |
| Tudor Investment Corp Et Al | 0 | $0 | 0.00% | −300,000−100.0% | Sold out |
| Millennium Management LLC | 0 | $0 | 0.00% | −238,852−100.0% | Sold out |
| Gabelli Funds LLC | 0 | $0 | 0.00% | −224,250−100.0% | Sold out |
| Renaissance Technologies LLC | 0 | $0 | 0.00% | −196,918−100.0% | Sold out |
| Gabelli & Co Investment Advisers, Inc. | 0 | $0 | 0.00% | −192,650−100.0% | Sold out |
| Qube Research & Technologies Ltd | 0 | $0 | 0.00% | −172,579−100.0% | Sold out |
| Blue Owl Capital Holdings LP | 0 | $0 | 0.00% | −1,599,660−100.0% | Sold out |
| Yakira Capital Management, Inc. | 0 | $0 | 0.00% | −144,826−100.0% | Sold out |
| Skandinaviska Enskilda Banken AB (publ) | 0 | $0 | 0.00% | −140,500−100.0% | Sold out |
| Goldman Sachs Group Inc | 0 | $0 | 0.00% | −137,520−100.0% | Sold out |
| Prelude Capital Management, LLC | 0 | $0 | 0.00% | −116,316−100.0% | Sold out |
| Water Island Capital LLC | 0 | $0 | 0.00% | −91,000−100.0% | Sold out |
| CSS LLC | 0 | $0 | 0.00% | −63,921−100.0% | Sold out |
| ADAR1 Capital Management, LLC | 0 | $0 | 0.00% | −63,622−100.0% | Sold out |
| BCK Capital Management LP | 0 | $0 | 0.00% | −43,642−100.0% | Sold out |
| Jane Street Group, LLC | 0 | $0 | 0.00% | −42,291−100.0% | Sold out |
| FMR LLC | 0 | $0 | 0.00% | −41,228−100.0% | Sold out |
| Carmignac Gestion | 0 | $0 | 0.00% | −39,468−100.0% | Sold out |
| Susquehanna International Group, LLP | 0 | $0 | 0.00% | −34,028−100.0% | Sold out |
| PenderFund Capital Management Ltd. | 0 | $0 | 0.00% | −23,580−100.0% | Sold out |
| JPMorgan Chase & Co | 0 | $0 | 0.00% | −27,184−100.0% | Sold out |
| HRT Financial LP | 0 | $0 | 0.00% | −24,737−100.0% | Sold out |
| Gamco Investors, Inc. Et Al | 0 | $0 | 0.00% | −15,188−100.0% | Sold out |
| GTS Securities LLC | 0 | $0 | 0.00% | −15,000−100.0% | Sold out |
| FNY Investment Advisers, LLC | 0 | $0 | 0.00% | −15,000−100.0% | Sold out |
| Vident Advisory, LLC | 0 | $0 | 0.00% | −11,270−100.0% | Sold out |
| Harvest Management LLC | 0 | $0 | 0.00% | −10,000−100.0% | Sold out |
| Woodline Partners LP | 0 | $0 | 0.00% | −10,000−100.0% | Sold out |
| Morgan Stanley | 0 | $0 | 0.00% | −2,186−100.0% | Sold out |
| EntryPoint Capital, LLC | 0 | $0 | 0.00% | −2,020−100.0% | Sold out |
| Rhumbline Advisers | 0 | $0 | 0.00% | −1,318−100.0% | Sold out |
| Group One Trading, L.P. | 0 | $0 | 0.00% | −1,197−100.0% | Sold out |
| Wells Fargo & Company | 0 | $0 | 0.00% | −1,150−100.0% | Sold out |
| Advisor Group Holdings, Inc. | 0 | $0 | 0.00% | −562−100.0% | Sold out |
| Banque Cantonale Vaudoise | 0 | $0 | 0.00% | −400−100.0% | Sold out |
| UBS Group AG | 0 | $0 | 0.00% | −380−100.0% | Sold out |
| Bank of America Corp | 0 | $0 | 0.00% | −283−100.0% | Sold out |
| Citigroup Inc | 0 | $0 | 0.00% | −110−100.0% | Sold out |
| Concord Wealth Partners | 0 | $0 | 0.00% | −100−100.0% | Sold out |
| CWM, LLC | 0 | $0 | 0.00% | −83−100.0% | Sold out |
| Beaird Harris Wealth Management, LLC | 0 | $0 | 0.00% | −12−100.0% | Sold out |
| Mine & Arao Wealth Creation & Management, LLC. | 0 | $0 | 0.00% | −10−100.0% | Sold out |
| Compass Wealth Management LLC | 0 | $0 | 0.00% | −9−100.0% | Sold out |